About Biopoly
Biopoly is a private company based in Fort Wayne, Indiana. It has reported $6,153,128 raised in seven offerings on Form D since June 2009. Its chief executive is Herbert Schwartz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 31, 2025 | Feb 6, 2025 | $1,096,500of $4.0M target | 1 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Jan 10, 2023 | Jan 24, 2023 | $300,000of $7.0M target | 4 | $75,000 | EquityRule 506(b) | Form D ↗ |
| Not yet | May 3, 2019 | $0of $2.0M target | 0 | — | Equity, Debt, CONVERTIBLE NOTERule 506(b), 4a5 | Form D ↗ |
| Jan 11, 2016 | Jan 19, 2016amended Nov 23, 2016 | $1,691,118of $5.0M target | 15 | $112K | EquityRule 506(b), 4a5 | Form D/A ↗1 earlier filing |
| Not yet | Oct 23, 2012 | $0of $5.0M target | 0 | — | Equity06, 46 | Form D ↗ |
| Not yet | Dec 15, 2010amended May 24, 2011 | $2,500,000of $3.0M target | 0 | — | Equity06, 46 | Form D/A ↗1 earlier filing |
| Jun 15, 2009 | Jun 23, 2009 | $565,510of $2.3M target | 1 | $565K | Equity06, 46 | Form D ↗ |
| Total, seven offerings | $6,153,128 | |||||
The filing for the offering first filed Dec 15, 2010 reports amount sold with no investors and amount sold but first sale marked as not yet made. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Biopoly's Form D filed Feb 6, 2025.
Earlier filings also listed Ryan Schlotterback (chief executive officer, last listed Jan 2023), Douglas Kampen (director, last listed Jan 2023), Timothy Claxton (director, last listed May 2019), Scott Glaze (director, last listed May 2019), Richard Tarr (director, last listed May 2019), Karl LaPan (director, last listed May 2019), Paul Gilbert (director, last listed Nov 2016) and Sabra Rowley (chief financial officer and director, last listed Oct 2012).